- Home
- News
- latamerica
- nerve development
Nerve Development Articles & Analysis
11 news found
The ARAI autoinjector has been developed by Aktiv with the support of the DOD and the U.S. Department of Health and Human Services (HHS) Biotechnology Advanced Research and Development Authority (BARDA) as a next generation autoinjector platform to address the shortfalls of previous autoinjectors, by improving usability, reliability, robustness, and drug ...
During the two days, Medovate will introduce attendees to examples of the SAFIRA® system on their stand enabling them to witness first-hand how the system works and the benefits it provides for safer peripheral nerve blocks. SAFIRA® has been developed by medical device company Medovate in collaboration with clinicians from the UK’s National Health ...
ByMedovate
This novel material adheres strongly to tissue through mechanical interlocking, making it a highly unique tool that can act as an atraumatic means of tissue repair. Further, as nerve connectors are becoming an increasingly popular part of the surgical management of peripheral nerve injuries, TISSIUM has developed methods to 3D print its material ...
ByTISSIUM
Creative Proteomics, an integrated CRO company committed to providing a full range of services to support various proteome-related research projects from identification of single proteins to large-scale proteomic studies, has recently upgraded its fully-developed Exosome Proteomics Service to identify and quantify the proteins in exosomes. ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the completion of enrollment in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study. ...
Alume Biosciences, Inc., a clinical stage biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today announced that the U.S. ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 million. ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the achievement of two milestones in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study. ...
Alume previously received a Phase I SBIR grant in 2019 from the NINDS to develop nerve illumination agents for surgical use. The Phase II SBIR grant is a follow-on 2–year award that will support testing of Alume's fluorescent nerve targeting agent in an ongoing Phase 1/2 clinical trial in patients undergoing Head and Neck Surgery. "Alume's ...
"Young children are particularly vulnerable to the toxic effects of lead, because lead can affect children's developing nerves and brains," said senior author Jianghong Liu, Ph.D., from the University of Pennsylvania School of Nursing, Philadelphia. ...
The four poisons at issue in the lawsuit are all organophosphate pesticides derived from nerve gas developed during World War II. They harm humans and wildlife by inhibiting the ability to produce cholinesterase, an enzyme necessary for the proper transmission of nerve impulses. ...